作者: A. Pitkänen , J-M. Hyttinen , P.J. Riekkinen
DOI: 10.1016/0143-4179(89)90028-0
关键词: Striatum 、 Seizure threshold 、 Hypothalamus 、 Neuropeptide 、 Internal medicine 、 Endocrinology 、 Kindling 、 Amygdala 、 Piriform cortex 、 Medicine 、 Somatostatin
摘要: Previous studies have shown that a somatostatin-depleting drug, cysteamine (CYS), suppresses kindled seizures. However, no data is available concerning the levels of somatostatin-like immunoreactivity (SLI) in rat brain after CYS administration. In present study, we used radioimmunoassay to measure SLI frontal cortex, amygdala + piriform hippocampus, striatum and hypothalamus: 1) control rats, 2) amygdala-kindled rats decapitated 14 days last stimulus, 3) stimulus but treated either 11 or 4) 4 hours before decapitation with (100 mg/kg, subcutaneously). The results showed that, compared controls, was elevated both ipsi lateral (28%, p = 0.0372) contralateral (17%, 0.0078) cortex. Compared given decreased cortex (to 71%, 0.0066) hippocampus 72%, 0.0027), only hippocampus. decapitation, did not differ from controls rats. conclusion, somatostatinergic system affected amygdala-kindling; relationship anatomical localization magnitude CYS-induced decrease seizure threshold needs be studied further.